Onyx, UCSF deal targets cancer-fighting projects

Onyx Pharmaceuticals Inc. is throwing open its net to UCSF cancer projects, hoping to pick and choose from a haul that could include preclinical and clinical cancer drug-development programs as well as new ways of designing drug trials...